Chapter category: Neurodegenerative Disease
Purines and Neuroprotection
Molecular and Cellular Biology
of Neuroprotection in the CNS
Edited by: Christian AlzheimerISBN: 0-306-47414-X
» Get more information about this book at landesbioscience.com «
Chapter authors:
Trevor W. Stone
The activation of adenosine A1, A2 and A3 receptors can protect neurones against damage generated by mechanical or hypoxic/ischaemic insults as well as excitotoxins. A1 receptors are probably effective by suppressing transmitter release and producing neuronal hyperpolarisation. They are less likely to be of therapeutic importance due to the plethora of side effects resulting from A1 agonism, although the existence of receptor subtypes and recent synthetic chemistry efforts to increase ligand selectivity, may yet yield clinically viable compounds.
Activation of A2A receptors can protect neurons, although there is much uncertainty as to whether agonists are acting centrally or via a peripheral mechanism such as altering blood flow or immune cell function. Selective antagonists at the A2A receptor, such as 4-(2-[7-amino-2-{2-furyl}{1,2,4}triazolo{2,3-a}{1,3,5}triazin -5-yl-amino]ethyl)phenol (ZM 241385) and 7-(2-phenylethyl)-5-amino-2-(2-furyl)-pyrazolo-[4,3e]-1,2,4-triazolo[1,5-c]pyrimidine (SCH 58261), can also protect against neuronal death produced by ischaemia or excitotoxicity. In addition, A2A receptor antagonists can reduce damage produced by combinations of subthreshold doses of the endogenous excitotoxin quinolinic acid and free radicals. Since the A2A receptors do not seem to be activated by normal endogenous levels of adenosine, their blockade should not generate significant side effects, so that A2A receptor antagonists appear to be promising candidates as new drugs for the prevention of neuronal damage. Adenosine A3 receptors have received less attention to date, but agonists are clearly able to afford protection against damage when administered chronically.
Given the disappointing lack of success of NMDA receptor antagonists in human stroke patients, despite their early promise in animal models, it is possible that A2A receptor antagonists could have a far greater clinical utility.
Additional chapters from this book:
Interleukin-10 and Psoriasis
K. Asadullah, W. Sterry and H.D. Volk
Interleukin (IL)-10 is an important immunoregulatory cytokine. One of its main biological function seems to be the limitation and termination of inflammatory responses. Remarkably, a relative deficien...
Role of IL-10 in Autoimmune Pathology
Almeras Lionel and Prin Lionel
The mechanisms involved in initiating and maintaining the inflammatory response associated with autoimmune diseases is yet to be defined. Nevertheless, cytokines with pro-inflammatory or anti-inflam...
Neurotrophins
Georg Dechan and Harald Neumann
Nerve growth factor was the first identified protein with anti-apoptotic activity on neurons. This prototypic neurotrophic factor, together with the three structurally and functionally re...
Purines and Neuroprotection
Trevor W. Stone
The activation of adenosine A1, A2 and A3 receptors can protect neurones against damage generated by mechanical or hypoxic/ischaemic insults as well as excitotoxins. A1 receptors are probably ...
Intracellular Ca2+ Handling
Rod J. Sayer
Intracellular Ca2+ is regulated within three major compartments: the cytosol, the endoplasmic reticulum and mitochondria. This Chapter reviews the mechanisms involved in handling of...
Excitatory Amino Acid Neurotoxicity
Thomas Gillessen, Samantha L. Budd and Stuart A. Lipton
The excitatory potency of the acidic amino acids glutamate and aspartate in various regions of the central nervous system (CNS) has been recognized since the 1960's.1,2 Nevertheless...
Neuroprotective Activity of Metabotropic Glutamate Receptor Ligands
Peter J. Flor, Giuseppe Battaglia, Ferdinando Nico
Metabotropic glutamate receptors form a family of currently eight subtypes (mGluR1 o -8), subdivided into three groups (I-III). Activation of group-II (mGluR2 and -3) or group-III metabotropic...
A Role for Glutamate Transporters in Neurodegenerative Diseases
Davide Trotti
In the mammalian central nervous system (CNS) L-glutamic acid acts as a chemical transmitter of excitatory signals. L-glutamate is released in the synaptic cleft and activates a multitude of h...
Vascular Endothelial Growth Factor
Hugo H. Marti
The striking structural and anatomical parallels between the vasculature and the nervous system is reflected by the fact that these two organ systems appear to use related mechanisms d...
Neuroprotective Strategies in Alzheimer's Disease
Christian Behl
Alzheimer's disease (AD) is a deadly progressive neurodegenerative disorder. Various aspects of the biochemistry of the AD-associated amyloid b protein (...
Neuroprotective Strategies in Animal and in vitro-Models of Neuronal Damage: Ischemia and Stroke
Matthias Endres and Ulrich Dirnagl
Cell death following cerebral ischemia is mediated by a complex pathophysiologic interaction of different mechanisms. In this Chapter we will outline the basic principles as well a...
Invasive Drug Delivery
Ulrike Blömer, Arnold Ganser and Michaela Scherr
The central nervous system is a very attractive target for new therapeutic strategies since many genes involved in neurological diseases are known and often only local low level...
Blood-Brain Barrier Drug Targeting Enables Neuroprotection in Brain Ischemia Following Delayed Intravenous Administration of Neurotrophins
William M. Pardridge
The bloodbrain barrier (BBB) is the ratelimiting step in the translation of neurotrophin neuroscience into clinically effective neurotherapeutics. Since neurotrophins do not cross ...
TGF-bs and Their Roles in the Regulation of Neuron Survival
Klaus Unsicker and Kerstin Krieglstein
Transforming growth factor-bs (TGF-bs) are a still growing superfamily of cytokines with widespread distribution and diverse biological functions. They f...
Heat Shock Proteins and Neuroprotection
Midori A. Yenari
In response to many metabolic disturbances and injuries including stroke, neurodegenerative disease, epilepsy and trauma, the cell mounts a stress response with induction of a vari...
Cellular and Molecular Determinants of Glial Scar Formation
Ann Logan and Martin Berry
Many axotomised neurons die and none of their severed axons regenerate after penetrant CNS injury in the adult. Debris and necrotic tissue is phagacytosed by hematogenous macrophages and microg...
Detrimental and Beneficial Effects of Injury-Induced Inflammation and Cytokine Expression in the Nervous System
Guido Stoll, Sebastian Jander and Michael Schroeter
Lesions in the nervous system induce rapid activation of glial cells and under certain conditions additional recruitment of granulocytes, T-cells and monocytes/macrophages from ...
Neuronal Survival and Cell Death Signaling Pathways
Richard S. Morrison, Yoshito Kinoshita, Mark D. Johnson, Saadi Ghatan, Joseph
Neuronal viability is maintained through a complex interacting network of signaling pathways that can be perturbed in response to a multitude of cellular stresses. A shift in the balance of si...
Fibroblast Growth Factors
Christian Alzheimer and Sabine Werner
The FGFs comprise a large group of structurally similar polypeptide mitogens which currently includes 22 different members. The first members of this family, FGF1 (acidic FGF, aFGF) and FGF2 (...
